Literature DB >> 11873523

Radioprotection of lung and esophagus by overexpression of the human manganese superoxide dismutase transgene.

Michael W Epperly1, Stacy Defilippi, Chrisitine Sikora, Joan Gretton, Joel S Greenberger.   

Abstract

Protection of normal tissue from radiation-induced damage has been demonstrated in the murine lung and esophagus using human manganese superoxide dismutase (MnSOD) plasmid/liposome complex (PL). C57BL/6J mice were injected intratracheally with MnSOD-PL, LacZ-PL, or metallothionein (MT2)-PL and irradiated 24 hours later at 2,000 cGy to the pulmonary cavity. Mice injected with MnSOD-PL had significantly increased survival compared with control, LacZ-PL, or MT2-PL irradiated mice. In an esophagitis model, male C3H/HeJ mice were injected intraesophageally with either MnSOD-PL or LacZ-PL and irradiated 24 hours later at 3,500 cGy to the pulmonary cavity. Mice injected with MnSOD-PL had significantly increased survival after irradiation at 3,500 cGy compared with control or LacZ-PL injected mice. However, orthotopic 3LL lung tumors in C57BL/6J mice were not protected from radiation following injection of MnSOD-PL, as seen by increased survival of mice with these tumors following irradiation. MnSOD-PL gene therapy protected normal lung and esophagus but not 3LL orthotopic lung tumors from radiation-induced damage.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11873523

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  10 in total

Review 1.  Modifying radiation damage.

Authors:  Kwanghee Kim; William H McBride
Journal:  Curr Drug Targets       Date:  2010-11       Impact factor: 3.465

2.  The zebrafish--Danio rerio--is a useful model for measuring the effects of small-molecule mitigators of late effects of ionizing irradiation.

Authors:  Michael W Epperly; Nathan Bahary; Mubina Quader; Valerie Dewald; Joel S Greenberger
Journal:  In Vivo       Date:  2012 Nov-Dec       Impact factor: 2.155

3.  Manganese superoxide dismutase is not protective in bovine pulmonary artery endothelial cells at systemic oxygen levels.

Authors:  Molly S Stitt-Fischer; Rachel K Ungerman; Daniel S Wilen; Karla Wasserloos; Lara M Renz; Shannon E Raub; Jim Peterson; Linda L Pearce
Journal:  Radiat Res       Date:  2010-09-28       Impact factor: 2.841

4.  Irradiated esophageal cells are protected from radiation-induced recombination by MnSOD gene therapy.

Authors:  Yunyun Niu; Hong Wang; Dominika Wiktor-Brown; Rebecca Rugo; Hongmei Shen; M Saiful Huq; Bevin Engelward; Michael Epperly; Joel S Greenberger
Journal:  Radiat Res       Date:  2010-04       Impact factor: 2.841

Review 5.  Current status of tumor radiogenic therapy.

Authors:  Feng-Ling Min; Hong Zhang; Wen-Jian Li
Journal:  World J Gastroenterol       Date:  2005-05-28       Impact factor: 5.742

Review 6.  Therapy for chronic obstructive pulmonary disease in the 21st century.

Authors:  Louise E Donnelly; Duncan F Rogers
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 7.  Novel therapeutic strategies in prostate cancer management using gene therapy in combination with radiation therapy.

Authors:  Spencer J Collis; Kevin Khater; Theodore L DeWeese
Journal:  World J Urol       Date:  2003-08-13       Impact factor: 3.661

8.  Strategies for discovery of small molecule radiation protectors and radiation mitigators.

Authors:  Joel S Greenberger; David Clump; Valerian Kagan; Hülya Bayir; John S Lazo; Peter Wipf; Song Li; Xiang Gao; Michael W Epperly
Journal:  Front Oncol       Date:  2012-01-13       Impact factor: 6.244

9.  Antioxidant Approaches to Management of Ionizing Irradiation Injury.

Authors:  Joel Greenberger; Valerian Kagan; Hulya Bayir; Peter Wipf; Michael Epperly
Journal:  Antioxidants (Basel)       Date:  2015-01-23

Review 10.  Gene Therapy for Systemic or Organ Specific Delivery of Manganese Superoxide Dismutase.

Authors:  Joel S Greenberger; Amitava Mukherjee; Michael W Epperly
Journal:  Antioxidants (Basel)       Date:  2021-06-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.